A detailed history of Hrt Financial LP transactions in Bioventus Inc. stock. As of the latest transaction made, Hrt Financial LP holds 77,808 shares of BVS stock, worth $453,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,808
Holding current value
$453,620
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.33 - $5.75 $336,908 - $447,396
77,808 New
77,808 $404,000
Q2 2022

Aug 12, 2022

SELL
$6.82 - $13.82 $570,281 - $1.16 Million
-83,619 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$11.65 - $15.28 $974,161 - $1.28 Million
83,619 New
83,619 $1.18 Million
Q4 2021

Feb 14, 2022

SELL
$12.37 - $16.77 $176,260 - $238,955
-14,249 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $195,211 - $245,795
14,249 New
14,249 $201,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $360M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.